Frontiers in Hematology (Mar 2024)

Case report: Donor lymphocyte infusion and blinatumomab as treatment for acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation

  • Flavia Antonucci,
  • Serena Marotta,
  • Maria Celentano,
  • Mariangela Pedata,
  • Cira Riccardi,
  • Cristina Luise,
  • Angela Carobene,
  • Simona Maria Muggianu,
  • Assunta Viola,
  • Mafalda Caputo,
  • Stefania Leone,
  • Ilaria Migliaccio,
  • Barbara Pocali,
  • Mirella Alberti,
  • Claudio Falco,
  • Mario Toriello,
  • Felicetto Ferrara,
  • Alessandra Picardi,
  • Alessandra Picardi

DOI
https://doi.org/10.3389/frhem.2024.1345884
Journal volume & issue
Vol. 3

Abstract

Read online

To date, the effect of blinatumomab and donor lymphocyte infusion association as a salvage treatment for acute lymphoblastic leukemia (ALL) relapse after allogeneic transplant procedure is still unknown. Here, we report a case report of a patient with early relapse of ALL after allogeneic hematopoietic stem cell transplant successfully treated with a combination of blinatumomab and DLI.

Keywords